Insider award: FMC (NYSE: FMC) CEO Brondeau gets 36 new shares

Rhea-AI Filing Summary

FMC Corporation reported a small insider share acquisition by its Chairman, CEO and President, Pierre R. Brondeau. On 01/15/2026, he acquired 36 shares of FMC common stock at a price of $0.00 per share. According to the footnote, these shares were issued as dividend equivalent rights tied to vested restricted stock units he already held, rather than a market purchase.

Following this issuance, Brondeau directly beneficially owned 300,906 shares of FMC common stock. The transaction was reported on a Form 4 filed for a single reporting person and reflects routine equity-based compensation rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BRONDEAU PIERRE R

Role Chairman, CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36	$0.00	--

Holdings After Transaction: Common Stock — 300,906 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRONDEAU PIERRE R

(Last) (First) (Middle)

FMC CORPORATION

2929 WALNUT STREET

(Street)

PHILADELPHIA PA 19104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FMC CORP [ FMC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		A		36(1)	A	$0	300,906	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.

	/s/ Sara Ponessa, as attorney in fact for Pierre R. Brondeau	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did FMC (FMC) report for Pierre R. Brondeau?

FMC reported that Chairman, CEO and President Pierre R. Brondeau acquired 36 shares of FMC common stock on 01/15/2026 at a price of $0.00 per share.

How did Pierre R. Brondeau receive the 36 FMC shares?

The 36 shares were issued as dividend equivalent rights in connection with vested restricted stock units held by Brondeau, rather than through a market purchase.

What is Pierre R. Brondeau’s FMC share ownership after this transaction?

After the reported transaction, Pierre R. Brondeau directly beneficially owned 300,906 shares of FMC common stock.

Was the FMC Form 4 filed for more than one reporting person?

No. The Form 4 was filed by one reporting person, identified as BRONDEAU PIERRE R, who is a director and officer of FMC.

What roles does Pierre R. Brondeau hold at FMC (FMC)?

Pierre R. Brondeau is listed as a Director and an Officer, with the title Chairman, CEO and President of FMC Corporation.